Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
JCI Insight
|
July 13, 2018
Repetitive ischemic injuries to the kidneys result in lymph node fibrosis and impaired healing
Omar H Maarouf, Mayuko Uehara, Vivek Kasinath, et al.
European Journal of Immunology
|
February 12, 2020
CD96 functions as a co-stimulatory receptor to enhance CD8<sup>+</sup> T cell activation and effector responses
Eugene Y Chiang, Patricia E de Almeida, Denise E de Almeida Nagata, et al.
JCI Insight
|
September 23, 2025
Repetitive ischemic injuries to the kidneys result in lymph node fibrosis and impaired healing
Omar H Maarouf, Mayuko Uehara, Vivek Kasinath, et al.
Immunity
|
March 9, 2022
Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8<sup>+</sup> T cell responses
Karl L Banta, Xiaozheng Xu, Avantika S Chitre, et al.
Molecular & Cellular Proteomics : MCP
|
July 17, 2019
A Platform for Extracellular Interactome Discovery Identifies Novel Functional Binding Partners for the Immune Receptors B7-H3/CD276 and PVR/CD155
Bushra Husain, Sree R Ramani, Eugene Chiang, et al.
The Journal of Biological Chemistry
|
October 23, 2015
Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics
Daniela Bumbaca Yadav, Vikas K Sharma, Charles Andrew Boswell, et al.
Cell Reports
|
October 4, 2018
The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function
Sairy Hernandez, Jing Qing, Rebecca Hong Thibodeau, et al.
Nature Medicine
|
June 30, 2009
Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease
Eugene Y Chiang, Ganesh A Kolumam, Xin Yu, et al.
Cancer Cell
|
February 26, 2022
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
Namrata S Patil, Barzin Y Nabet, Sören Müller, et al.
Journal for Immunotherapy of Cancer
|
June 27, 2017
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31<sup>st</sup>Annual Meeting of the Society for Immunotherapy of Cancer, 2016
Prasad S Adusumilli, Edward Cha, Mark Cornfeld, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
JCI Insight
|
July 13, 2018
Repetitive ischemic injuries to the kidneys result in lymph node fibrosis and impaired healing
Omar H Maarouf, Mayuko Uehara, Vivek Kasinath, et al.
European Journal of Immunology
|
February 12, 2020
CD96 functions as a co-stimulatory receptor to enhance CD8<sup>+</sup> T cell activation and effector responses
Eugene Y Chiang, Patricia E de Almeida, Denise E de Almeida Nagata, et al.
JCI Insight
|
September 23, 2025
Repetitive ischemic injuries to the kidneys result in lymph node fibrosis and impaired healing
Omar H Maarouf, Mayuko Uehara, Vivek Kasinath, et al.
Immunity
|
March 9, 2022
Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8<sup>+</sup> T cell responses
Karl L Banta, Xiaozheng Xu, Avantika S Chitre, et al.
Molecular & Cellular Proteomics : MCP
|
July 17, 2019
A Platform for Extracellular Interactome Discovery Identifies Novel Functional Binding Partners for the Immune Receptors B7-H3/CD276 and PVR/CD155
Bushra Husain, Sree R Ramani, Eugene Chiang, et al.
The Journal of Biological Chemistry
|
October 23, 2015
Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics
Daniela Bumbaca Yadav, Vikas K Sharma, Charles Andrew Boswell, et al.
Cell Reports
|
October 4, 2018
The Kinase Activity of Hematopoietic Progenitor Kinase 1 Is Essential for the Regulation of T Cell Function
Sairy Hernandez, Jing Qing, Rebecca Hong Thibodeau, et al.
Nature Medicine
|
June 30, 2009
Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease
Eugene Y Chiang, Ganesh A Kolumam, Xin Yu, et al.
Cancer Cell
|
February 26, 2022
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
Namrata S Patil, Barzin Y Nabet, Sören Müller, et al.
Journal for Immunotherapy of Cancer
|
June 27, 2017
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31<sup>st</sup>Annual Meeting of the Society for Immunotherapy of Cancer, 2016
Prasad S Adusumilli, Edward Cha, Mark Cornfeld, et al.
Page
of 5